Rifampin is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- All forms of tuberculosis.
- Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
- Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
- Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
- Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
- Brucellosis
- Bartonella infections
- Q-fever and rickettsialinfections
- Cutaneous leishmaniasis
- Legionella infections
- Anthrax infections
- NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 5, 2017
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifampin
ID - 545265
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/06/05/
PB - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545265/all/Rifampin
ER -